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Background
The increase in the number of elderly people results in
the exponential increase of cancer incidence, though we
are wondering how that of ATL change.
Materials and method
We assessed the therapy and outcome of newly diag-
nosed or referred 66 ATL patients from 2006 to 2009.
Serum of patient was preserved in freezer to detect solu-
ble proteins, sCD30 and sIL-2R, using ELISA.
Results
More than 70% of newly diagnosed ATL patients were
elderly persons aged 65 or older. Twenty-three of 66
patients at age from 41 to 61-year-old underwent allo-
geneic hematopoietic stem cell transplantation (allo-
HSCT) in our hospital. On the other hand, 38 patients
were not suitable for allo-HSCT therapy. Their ages
were from 51 to 89-year-old and elderly aged 65-year-
old and over occupied 73.3% of them (22 of 30, who we
confirmed their outcome). Seven patients of them died
before treatment or during the primary therapy. Then,
we focused patients cause acute transformation from
chronic type to figure out the timing of primary inter-
vention and the efficiency of the therapy. Elevating
sCD30 was observed earlier than other markers (sIL-2R,
LDH) due to acute transformation and reduced by the
treatment regimen changed even during treatment of
relapse (recurrence).
Discussion
Retrospective monitoring of soluble protein in serum
was found to be effective to confirm the progression of
disease as well as the remission state following remission
induction therapy and maintenance therapy (Nishioka C,
Takemoto S, et al.). And sCD30 elevated earlier than the
other markers indicating that it is useful to predict the
onset of acute crisis in ATL and detect the timing of
the chemotherapy beginning. Successful intervention at
the best timing and change of therapy in aggressive
phase and indolent phase, respectively, resulted in disap-
pearance of ATL cells and accomplished complete
remission as long as we can.
Conclusions
Changes in ATL patients by the advent of aged society
indicate early therapeutic intervention and selection of
appropriate treatment is required. If patients relapse
after chemotherapy, a new therapy with an anti-CCR4
antibody, which is under development, may become an
option, because our elderly patient achieved remission
state by this therapy in the clinical study.
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